APLS logo

Apellis Pharmaceuticals, Inc. (APLS) Depreciation and amortization

annual D&A:

$1.80M+$13.00K(+0.73%)
December 31, 2024

Summary

  • As of today (August 4, 2025), APLS annual depreciation & amortization is $1.80 million, with the most recent change of +$13.00 thousand (+0.73%) on December 31, 2024.
  • During the last 3 years, APLS annual D&A has risen by +$305.00 thousand (+20.44%).
  • APLS annual D&A is now at all-time high.

Performance

APLS Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLSincome statement metrics

quarterly D&A:

$446.00K$0.00(0.00%)
June 30, 2025

Summary

  • As of today (August 4, 2025), APLS quarterly depreciation & amortization is $446.00 thousand, unchanged on June 30, 2025.
  • Over the past year, APLS quarterly D&A has dropped by -$3000.00 (-0.67%).
  • APLS quarterly D&A is now -21.75% below its all-time high of $570.00 thousand, reached on December 31, 2023.

Performance

APLS quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLSincome statement metrics

TTM D&A:

$1.80M-$3000.00(-0.17%)
June 30, 2025

Summary

  • As of today (August 4, 2025), APLS TTM depreciation & amortization is $1.80 million, with the most recent change of -$3000.00 (-0.17%) on June 30, 2025.
  • Over the past year, APLS TTM D&A has dropped by -$72.00 thousand (-3.85%).
  • APLS TTM D&A is now -6.12% below its all-time high of $1.91 million, reached on September 30, 2024.

Performance

APLS TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLSincome statement metrics

APLS Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+0.7%-0.7%-3.9%
3 y3 years+20.4%+30.4%+32.8%
5 y5 years+201.5%+265.6%+187.8%

APLS Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+20.4%-21.8%+30.4%-6.1%+32.8%
5 y5-yearat high+201.5%-21.8%+265.6%-6.1%+187.8%
alltimeall timeat high>+9999.0%-21.8%>+9999.0%-6.1%>+9999.0%

APLS Depreciation and amortization History

DateAnnualQuarterlyTTM
Jun 2025
-
$446.00K(0.0%)
$1.80M(-0.2%)
Mar 2025
-
$446.00K(-1.8%)
$1.80M(+0.1%)
Dec 2024
$1.80M(+0.7%)
$454.00K(+0.9%)
$1.80M(-6.1%)
Sep 2024
-
$450.00K(+0.2%)
$1.91M(+2.4%)
Jun 2024
-
$449.00K(+1.1%)
$1.87M(+2.1%)
Mar 2024
-
$444.00K(-22.1%)
$1.83M(+2.5%)
Dec 2023
$1.78M(+14.9%)
$570.00K(+40.7%)
$1.78M(+4.5%)
Sep 2023
-
$405.00K(-1.2%)
$1.71M(+2.9%)
Jun 2023
-
$410.00K(+2.8%)
$1.66M(+4.3%)
Mar 2023
-
$399.00K(-19.1%)
$1.59M(+2.5%)
Dec 2022
$1.55M(+4.0%)
$493.00K(+38.1%)
$1.55M(+8.2%)
Sep 2022
-
$357.00K(+4.4%)
$1.44M(+6.1%)
Jun 2022
-
$342.00K(-5.0%)
$1.35M(-7.3%)
Mar 2022
-
$360.00K(-4.3%)
$1.46M(-2.3%)
Dec 2021
$1.49M
$376.00K(+37.2%)
$1.49M(+6.9%)
Sep 2021
-
$274.00K(-38.8%)
$1.40M(-2.9%)
DateAnnualQuarterlyTTM
Jun 2021
-
$448.00K(+13.7%)
$1.44M(+29.3%)
Mar 2021
-
$394.00K(+40.7%)
$1.11M(+29.3%)
Dec 2020
$859.00K(+44.1%)
$280.00K(-11.1%)
$859.00K(+8.1%)
Sep 2020
-
$315.00K(+158.2%)
$795.00K(+27.4%)
Jun 2020
-
$122.00K(-14.1%)
$624.00K(0.0%)
Mar 2020
-
$142.00K(-34.3%)
$624.00K(+4.7%)
Dec 2019
$596.00K(>+9900.0%)
$216.00K(+50.0%)
$596.00K(+56.8%)
Sep 2019
-
$144.00K(+18.0%)
$380.00K(+61.0%)
Jun 2019
-
$122.00K(+7.0%)
$236.00K(+107.0%)
Mar 2019
-
$114.00K(>+9900.0%)
$114.00K(>+9900.0%)
Dec 2018
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2018
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2018
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2018
-
$0.00
$0.00
Dec 2017
$0.00(-100.0%)
-
-
Dec 2014
$6600.00(+4.8%)
-
-
Dec 2013
$6300.00
-
-

FAQ

  • What is Apellis Pharmaceuticals, Inc. annual depreciation & amortization?
  • What is the all time high annual D&A for Apellis Pharmaceuticals, Inc.?
  • What is Apellis Pharmaceuticals, Inc. annual D&A year-on-year change?
  • What is Apellis Pharmaceuticals, Inc. quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Apellis Pharmaceuticals, Inc.?
  • What is Apellis Pharmaceuticals, Inc. quarterly D&A year-on-year change?
  • What is Apellis Pharmaceuticals, Inc. TTM depreciation & amortization?
  • What is the all time high TTM D&A for Apellis Pharmaceuticals, Inc.?
  • What is Apellis Pharmaceuticals, Inc. TTM D&A year-on-year change?

What is Apellis Pharmaceuticals, Inc. annual depreciation & amortization?

The current annual D&A of APLS is $1.80M

What is the all time high annual D&A for Apellis Pharmaceuticals, Inc.?

Apellis Pharmaceuticals, Inc. all-time high annual depreciation & amortization is $1.80M

What is Apellis Pharmaceuticals, Inc. annual D&A year-on-year change?

Over the past year, APLS annual depreciation & amortization has changed by +$13.00K (+0.73%)

What is Apellis Pharmaceuticals, Inc. quarterly depreciation & amortization?

The current quarterly D&A of APLS is $446.00K

What is the all time high quarterly D&A for Apellis Pharmaceuticals, Inc.?

Apellis Pharmaceuticals, Inc. all-time high quarterly depreciation & amortization is $570.00K

What is Apellis Pharmaceuticals, Inc. quarterly D&A year-on-year change?

Over the past year, APLS quarterly depreciation & amortization has changed by -$3000.00 (-0.67%)

What is Apellis Pharmaceuticals, Inc. TTM depreciation & amortization?

The current TTM D&A of APLS is $1.80M

What is the all time high TTM D&A for Apellis Pharmaceuticals, Inc.?

Apellis Pharmaceuticals, Inc. all-time high TTM depreciation & amortization is $1.91M

What is Apellis Pharmaceuticals, Inc. TTM D&A year-on-year change?

Over the past year, APLS TTM depreciation & amortization has changed by -$72.00K (-3.85%)
On this page